To evaluate neutralizing antibody responses against the parental WA1/2020 strain of the virus, as well as against the omicron BA.1 and BA.2 variants
No takes yet. Share an insight, caveat, or question.
A 2022 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: